Menu

Kenneth Krisko

Partner

I work closely with my clients to understand their business and strategic objectives and to structure and negotiate transactions to meet those objectives.

kkrisko@cooley.com

Kenneth Krisko's practice focuses on the representation of public and private life sciences companies in a broad range of commercial and corporate finance matters. He advises clients regularly with respect to complex commercial transactions designed to maximize the value of pharmaceutical products and technology assets, including technology licenses and acquisitions, research and development collaborations, distribution and manufacturing agreements, and profit-sharing and co-promotion arrangements.

Download full bio 

Experience

  • Immatics Enters Global Exclusive License Agreement With Bristol Myers Squibb 

  • Poseida Therapeutics Enters Research Collaboration With Takeda to Develop Novel Gene Therapies 

  • Merus Enters Collaboration With Eli Lilly to Develop New Generation of Cancer Treatments 

  • Talis Biomedical – $254 Million IPO 

  • Hansa Biopharma Announces Collaboration with Sarepta 

  • View all

Education

  • University of Virginia School of Law
    JD, 1995

  • Virginia Tech
    BS, Aerospace and Ocean Engineering
    1987


Admissions & Credentials

District of Columbia

Virginia

Memberships

  • American Bar Association

Rankings & Accolades

    Legal 500: Key Lawyer – Healthcare: Life Sciences (2021)